RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
THERAPEUTIC DRUG MONITORING
Collezione ASL Città di Torino

Items : 13

Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect? in Therapeutic drug monitoring / Ther Drug Monit. 2023 Apr 1;45(2):282-284. doi: 10.1097/FTD.0000000000001072. Epub 2023 Jan 10.

2023
ASL Città di Torino

Cattaneo D; Bonora S; Meraviglia P; Vimercati S; Antinori S; Gervasoni C;

Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):165-168. doi: 10.1097/FTD.0000000000000729.

2020
ASL Città di Torino

D'Avolio A; Cattaneo D; Veronese A; Corona A; Agarossi A;

Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):309-314. doi: 10.1097/FTD.0000000000000680.

2020
ASL Città di Torino

Franco V; Baruffi K; Marchiselli R; Crema F; Fattore C; Romigi A; De Giorgis V; Tartara E; Elia M; D'Avolio A; Perucca E;

LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device. in Therapeutic drug monitoring / Ther Drug Monit. 2019 Jun;41(3):331-339. doi: 10.1097/FTD.0000000000000600.

2019
ASL Città di Torino

D?Urso A; Cangemi G; Barco S; Striano P; D?Avolio A; de Grazia U;

A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance. in Therapeutic drug monitoring / Ther Drug Monit. 2018 Oct;40(5):602-609. doi: 10.1097/FTD.0000000000000536.

2018
ASL Città di Torino

D?Avolio A; Corcione S; Danesi R; Arrigoni E; Fatiguso G; Di Paolo A; Cusato J; Allegra S;

Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasma. in Therapeutic drug monitoring / Ther Drug Monit. 2013 Dec;35(6):853-8. doi: 10.1097/FTD.0b013e31829403b1.

2013
ASL Città di Torino

D'Avolio A; Peila E; Simiele M; Pensi D; Baietto L; Cusato J; Cinnirella G; De Rosa F; Di Perri G;

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a.

2012
ASL Città di Torino

D'Avolio A; Ciancio A; Siccardi M; Smedile A; Simiele M; Cusato J; Baietto L; Aguilar Marucco D; Cariti G; Calcagno A; Gonzalez de Requena D; Sciandra M; Troshina G; Caviglia GP; Bonora S; Rizzetto M; Di Perri G;

Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Apr;34(2):165-70. doi: 10.1097/FTD.0b013e31824bf778.

2012
ASL Città di Torino

D?Avolio A; Ciancio A; Siccardi M; Smedile A; Baietto L; Simiele M; Marucco DA; Cariti G; Calcagno A; de Requena DG; Sciandra M; Cusato J; Troshina G; Bonora S; Rizzetto M; Di Perri G;

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2010 Feb;32(1):86-92. doi: 10.1097/FTD.0b013e3181cacbd0.

2010
ASL Città di Torino

D'Avolio A; Simiele M; Baietto L; Siccardi M; Sciandra M; Patanella S; Bonora S; Di Perri G;

Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. in Therapeutic drug monitoring / Ther Drug Monit. 2009 Feb;31(1):104-9. doi: 10.1097/FTD.0b013e31819476fa.

2009
ASL Città di Torino

Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Patanella S; Siccardi M; Sciandra M; Di Perri G;

A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting. in Therapeutic drug monitoring / Ther Drug Monit. 2008 Feb;30(1):90-4. doi: 10.1097/FTD.0b013e31815f4f7e.

2008
ASL Città di Torino

D'Avolio A; Baietto L; De Rosa FG; Garazzino S; Sciandra M; Siccardi M; Bonora S; Di Perri G;

An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2008 Dec;30(6):662-9. doi: 10.1097/FTD.0b013e318189596d.

2008
ASL Città di Torino

D'Avolio A; Baietto L; Siccardi M; Sciandra M; Simiele M; Oddone V; Bonora S; Di Perri G;

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2006 Feb;28(1):110-5. doi: 10.1097/01.ftd.0000179421.25337.62.

2006
ASL Città di Torino

D'Avolio A; Sciandra M; de Requena DG; Ibañez A; Bonora S; Di Perri G;